Literature DB >> 16192412

Relationship of individual cognitive abilities to specific components of decisional capacity among middle-aged and older patients with schizophrenia.

Barton W Palmer1, Dilip V Jeste.   

Abstract

Prior empirical studies suggest that cognitive impairment is the strongest predictor of capacity to consent to research among persons with schizophrenia. Yet, despite the frequency and importance of cognitive deficits and impaired decisional capacity in schizophrenia, the scope of neuropsychological testing in most published reports in this area has been relatively narrow. In the present study of 70 people with schizophrenia aged 40 to 70 years we evaluated decisional capacity with the MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR). Participants were also evaluated with standardized rating scales of psychopathology and level of insight and with a comprehensive neuropsychological test battery that permitted evaluation of 7 specific cognitive abilities. Results showed that the strongest correlates of capacity (particularly, understanding and appreciation of disclosed information) were cognitive test scores, but there was little evidence of differential relationships between individual cognitive abilities and specific dimensions of capacity. Understanding was also correlated with severity of negative symptoms and of general psychopathology, but not with age, education, severity of positive or depressive symptoms, or level of insight. Understanding improved over successive presentations of consent-relevant information. The results suggest that age and diagnosis should not be viewed as determinants of decisional capacity; investigators should be alert to the presence of cognitive deficits, as well as negative symptoms. Also, an interactive dialogue between patient and investigator with repeated presentation of information is likely to aid understanding of disclosed information among patients with schizophrenia.

Entities:  

Mesh:

Year:  2005        PMID: 16192412      PMCID: PMC2632184          DOI: 10.1093/schbul/sbj002

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  33 in total

1.  Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research.

Authors:  S Y Kim; E D Caine; G W Currier; A Leibovici; J M Ryan
Journal:  Am J Psychiatry       Date:  2001-05       Impact factor: 18.112

2.  The MacArthur Treatment Competence Study. III: Abilities of patients to consent to psychiatric and medical treatments.

Authors:  Thomas Grisso; Paul S Appelbaum
Journal:  Law Hum Behav       Date:  1995-04

3.  Decisional capacity for informed consent in schizophrenia research.

Authors:  W T Carpenter; J M Gold; A C Lahti; C A Queern; R R Conley; J J Bartko; J Kovnick; P S Appelbaum
Journal:  Arch Gen Psychiatry       Date:  2000-06

Review 4.  Assessing decisional capacity for clinical research or treatment: a review of instruments.

Authors:  Laura B Dunn; Milap A Nowrangi; Barton W Palmer; Dilip V Jeste; Elyn R Saks
Journal:  Am J Psychiatry       Date:  2006-08       Impact factor: 18.112

5.  Perspectives of patients with schizophrenia and psychiatrists regarding ethically important aspects of research participation.

Authors:  L W Roberts; T D Warner; J L Brody
Journal:  Am J Psychiatry       Date:  2000-01       Impact factor: 18.112

6.  The California Scale of Appreciation: a new instrument to measure the appreciation component of capacity to consent to research.

Authors:  Elyn R Saks; Laura B Dunn; Barbara J Marshall; Gauri V Nayak; Shahrokh Golshan; Dilip V Jeste
Journal:  Am J Geriatr Psychiatry       Date:  2002 Mar-Apr       Impact factor: 4.105

7.  Improving understanding of research consent in middle-aged and elderly patients with psychotic disorders.

Authors:  Laura B Dunn; Laurie A Lindamer; Barton W Palmer; Shahrokh Golshan; Lawrence J Schneiderman; Dilip V Jeste
Journal:  Am J Geriatr Psychiatry       Date:  2002 Mar-Apr       Impact factor: 4.105

8.  Heterogeneity in functional status among older outpatients with schizophrenia: employment history, living situation, and driving.

Authors:  Barton W Palmer; Robert K Heaton; Julie A Gladsjo; Jovier D Evans; Thomas L Patterson; Shahrokh Golshan; Dilip V Jeste
Journal:  Schizophr Res       Date:  2002-06-01       Impact factor: 4.939

Review 9.  Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

Authors:  M F Green; R S Kern; D L Braff; J Mintz
Journal:  Schizophr Bull       Date:  2000       Impact factor: 9.306

10.  Enhancing informed consent for research and treatment.

Authors:  L B Dunn; D V Jeste
Journal:  Neuropsychopharmacology       Date:  2001-06       Impact factor: 7.853

View more
  23 in total

1.  Decisional capacity and consent for schizophrenia research.

Authors:  Allison R Kaup; Laura B Dunn; Elyn R Saks; Dilip V Jeste; Barton W Palmer
Journal:  IRB       Date:  2011 Jul-Aug

2.  Capacity to make medical treatment decisions in multiple sclerosis: a potentially remediable deficit.

Authors:  Michael R Basso; Philip J Candilis; Jay Johnson; Courtney Ghormley; Dennis R Combs; Taeh Ward
Journal:  J Clin Exp Neuropsychol       Date:  2010-12       Impact factor: 2.475

Review 3.  Emerging empirical evidence on the ethics of schizophrenia research.

Authors:  Laura B Dunn; Philip J Candilis; Laura Weiss Roberts
Journal:  Schizophr Bull       Date:  2005-10-19       Impact factor: 9.306

Review 4.  Informed consent in dental care and research for the older adult population: A systematic review.

Authors:  Amrita Mukherjee; Alicia A Livinski; Joseph Millum; Steffany Chamut; Shahdokht Boroumand; Timothy J Iafolla; Margo R Adesanya; Bruce A Dye
Journal:  J Am Dent Assoc       Date:  2017-01-05       Impact factor: 3.634

Review 5.  Assessment of Healthcare Decision-making Capacity.

Authors:  Barton W Palmer; Alexandrea L Harmell
Journal:  Arch Clin Neuropsychol       Date:  2016-08-22       Impact factor: 2.813

Review 6.  Ethical, Legal and Forensic Issues in Geriatric Psychiatry.

Authors:  Rajesh R Tampi; Juan Young; Silpa Balachandran; Dhweeja Dasarathy; Deena Tampi
Journal:  Curr Psychiatry Rep       Date:  2018-01-25       Impact factor: 5.285

7.  Treatment decision-making capacity in non-consensual psychiatric treatment: a multicentre study.

Authors:  G Mandarelli; F Carabellese; G Parmigiani; F Bernardini; L Pauselli; R Quartesan; R Catanesi; S Ferracuti
Journal:  Epidemiol Psychiatr Sci       Date:  2017-03-09       Impact factor: 6.892

8.  Prevalence and correlates of adequate performance on a measure of abilities related to decisional capacity: differences among three standards for the MacCAT-CR in patients with schizophrenia.

Authors:  Laura B Dunn; Barton W Palmer; Paul S Appelbaum; Elyn R Saks; Gregory A Aarons; Dilip V Jeste
Journal:  Schizophr Res       Date:  2006-10-03       Impact factor: 4.939

9.  Cognitive profiles in persons with chronic schizophrenia.

Authors:  Sharron E Dawes; Dilip V Jeste; Barton W Palmer
Journal:  J Clin Exp Neuropsychol       Date:  2011-06-28       Impact factor: 2.475

Review 10.  What do we know about neuropsychological aspects of schizophrenia?

Authors:  Barton W Palmer; Sharron E Dawes; Robert K Heaton
Journal:  Neuropsychol Rev       Date:  2009-07-30       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.